Top

memo - Magazine of European Medical Oncology

Content (21 Articles)

editorial

Cellular immunotherapy for cancer. Past, present, future

Alexandros Spyridonidis

editorial

Breast cancer—advanced stage: “cure—still a long way to go?”

Herbert Stöger

editorial

Clinical practice guidelines in oncology—achievements and challenges

Günther Gastl

short review

Immunotherapy for nonsmall-cell lung cancer

Astrid Belalcazar, Luis E. Raez, Edgardo S. Santos

short review

Immunotherapeutic approaches targeting prostate cancer and its microenvironment

Robert Zeiser

short review

Natural killer cell based immunotherapy for eradication of minimal residual disease in patients with malignant disorders

Panagiotis D. Tsirigotis, Nikolaos Papanikolaou

short review

The role of biomarkers in the choice of therapy in breast cancer

Brigitte Mlineritsch, Sigrun Ressler, Richard Greil

review

Evolving strategies to overcome endocrine resistance in breast cancer

Michael Hubalek, Christine Brunner, Christian Marth

review

What’s new in metastatic breast cancer?

Rupert Bartsch

short review

Surgical removal of the primary?—The role it plays in stage IV breast cancer

Florian Fitzal

short review

The role of Positron Emission Tomography/Computer Tomography (PET/CT) in the diagnosis, staging, characterization, and therapy of breast cancer

Zoltán Lőcsei, Katalin Hideghéty, Zsuzsanna Kahán

short review

Breast cancer: is there a need for biopsy of metastases?

Flora Zagouri, Martin Filipits

short review

Advanced breast cancer: new imaging techniques for detection of metastases

Helmut Schoellnast, Christian Gstettner

original report

Treatment outcome in AML: a single-centre experience in an unselected patient cohort

Kathrin Strasser-Weippl, Martin Schreder, Niklas Zojer, Heinz Ludwig

case report

Sjögren syndrome complicated with hairy-cell leukemia: a case-based review

Noushin Bayat, Hasan Bagheri, Reza Karbasi-Afshar, Alireza Saadat, Farhad Sarrafzadeh, Amin Saburi

short review

Lung cancer screening: current evidence and recommendations

Michael Mark, Martin Brutsche, Oliver Gautschi

review

Interventional therapy for symptomatic bronchial carcinoma

Christian Geltner

case report

Is distinct EGFR mutation status proof of second simultaneous primary non-small cell lung cancer?

Ulf Petrausch, Verena Tischler, Walter Weder, Rolf Stahel, Alex Soltermann

short review

Recent advances and future challenges in the treatment of upper gastrointestinal malignancies

Dieter Koeberle, Anna Dorothea Wagner

comment

Advances in haematology and oncology 2011: hepatocellular carcinoma (HCC)

Markus Peck-Radosavljevic

short review

Highlights in the adjuvant treatment of colon cancer from annual meetings 2011

Gudrun Resch, Josef Thaler

Apr 12

Issue: Special Issue 1/2012

Proceedings of the Annual Meetingof the Austrian Society of Haematology and Oncology

Sep 12

Issue: 3/2012

Latest issues

memo - Magazine of European Medical Oncology 2/2024
memo - Magazine of European Medical Oncology 1/2024
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology
memo - Magazine of European Medical Oncology 1/2024
memo - Magazine of European Medical Oncology 9/2023
A CONGRESS DIGEST ON RADIOLABELED THERANOSTICS FOR SOLID TUMORS. Report from the 36th Annual Congress of the European Association of Nuclear Medicine (EANM), September 9th – 13th, 2023, Vienna
memo - Magazine of European Medical Oncology 8/2023
A GLOBAL CONGRESS DIGEST ON LUNG CANCER. Report from the International Association for the Study of Lung Cancer (IASLC) 2023 World Conference on Lung Cancer, September 9th-12th , hybrid congress
memo - Magazine of European Medical Oncology 4/2023
memo - Magazine of European Medical Oncology 11/2023
A GLOBAL CONGRESS DIGEST ON LUNG CANCER. Report from the ESMO Hybrid Congress , 20th – 24th October 2023, Madrid, Spain
memo - Magazine of European Medical Oncology 10/2023
A GLOBAL CONGRESS DIGEST ON CHRONIC LYMPHOCYTIC LEUKEMIA. Report from International Workshop on Chronic Lymphocytic Leukemia (XX iwCLL 2023), 6th–9th October, 2023, Boston, USA
memo - Magazine of European Medical Oncology 12/2023
A GLOBAL CONGRESS DIGEST ON TARGETED THERAPIES IN B-CELL MALIGNANCIES. Report from the American Society of Hematology (ASH) Annual Meeting, December 9–12, 2023
memo - Magazine of European Medical Oncology 3/2023

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

memo - Magazine of European Medical Oncology

Issue 2/2012

Content (21 Articles)

Cellular immunotherapy for cancer. Past, present, future

Breast cancer—advanced stage: “cure—still a long way to go?”

Clinical practice guidelines in oncology—achievements and challenges

Immunotherapy for nonsmall-cell lung cancer

Immunotherapeutic approaches targeting prostate cancer and its microenvironment

Natural killer cell based immunotherapy for eradication of minimal residual disease in patients with malignant disorders

The role of biomarkers in the choice of therapy in breast cancer

Evolving strategies to overcome endocrine resistance in breast cancer

What’s new in metastatic breast cancer?

Surgical removal of the primary?—The role it plays in stage IV breast cancer

The role of Positron Emission Tomography/Computer Tomography (PET/CT) in the diagnosis, staging, characterization, and therapy of breast cancer

Breast cancer: is there a need for biopsy of metastases?

Advanced breast cancer: new imaging techniques for detection of metastases

Treatment outcome in AML: a single-centre experience in an unselected patient cohort

Sjögren syndrome complicated with hairy-cell leukemia: a case-based review

Lung cancer screening: current evidence and recommendations

Interventional therapy for symptomatic bronchial carcinoma

Is distinct EGFR mutation status proof of second simultaneous primary non-small cell lung cancer?

Recent advances and future challenges in the treatment of upper gastrointestinal malignancies

Advances in haematology and oncology 2011: hepatocellular carcinoma (HCC)

Highlights in the adjuvant treatment of colon cancer from annual meetings 2011

Latest issues

memo - Magazine of European Medical Oncology 2/2024

Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology

memo - Magazine of European Medical Oncology 1/2024

A CONGRESS DIGEST ON RADIOLABELED THERANOSTICS FOR SOLID TUMORS. Report from the 36th Annual Congress of the European Association of Nuclear Medicine (EANM), September 9th – 13th, 2023, Vienna

A GLOBAL CONGRESS DIGEST ON LUNG CANCER. Report from the International Association for the Study of Lung Cancer (IASLC) 2023 World Conference on Lung Cancer, September 9th-12th , hybrid congress

memo - Magazine of European Medical Oncology 4/2023

A GLOBAL CONGRESS DIGEST ON LUNG CANCER. Report from the ESMO Hybrid Congress , 20th – 24th October 2023, Madrid, Spain

A GLOBAL CONGRESS DIGEST ON CHRONIC LYMPHOCYTIC LEUKEMIA. Report from International Workshop on Chronic Lymphocytic Leukemia (XX iwCLL 2023), 6th–9th October, 2023, Boston, USA

A GLOBAL CONGRESS DIGEST ON TARGETED THERAPIES IN B-CELL MALIGNANCIES. Report from the American Society of Hematology (ASH) Annual Meeting, December 9–12, 2023

memo - Magazine of European Medical Oncology 3/2023

Keynote webinar | Spotlight on antibody–drug conjugates in cancer